Structural and metabolic brain abnormalities in COVID-19 patients with sudden loss of smell
Month: June 2021
Positive results presented of the VISION trial
During the virtual ASCO 2021 meeting, the highly anticipated results of the phase III study with radioligand therapy 177Lu-PSMA-617 in patients with advanced prostate cancer (VISION trial) were presented.
Continue reading “Positive results presented of the VISION trial”